|
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Maryland
|
27-0467113
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
Common Stock, $0.01 par value
|
ARI
|
New York Stock Exchange
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
Non-accelerated filer
|
|
☐
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
Emerging growth company
|
|
☐
|
Item 1.
|
||
Item 1A.
|
||
Item 1B.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
||
Item 5.
|
||
Item 6.
|
||
Item 7.
|
||
Item 7A.
|
||
Item 8.
|
||
Item 9.
|
||
Item 9A.
|
||
Item 9B.
|
||
|
||
Item 10.
|
||
Item 11.
|
||
Item 12.
|
||
Item 13.
|
||
Item 14.
|
||
|
||
Item 15.
|
||
Item 16.
|
||
|
•
|
Our board of directors is composed of a majority of independent directors. The Audit Committee, Compensation
|
•
|
In order to foster the highest standards of ethics and conduct in all business relationships, we have adopted a Code of Business Conduct and Ethics and Corporate Governance Guidelines, which cover a wide range of business practices and procedures that apply to all of our directors and officers. In addition, we have implemented Whistle Blowing Procedures for Accounting and Auditing Matters (the "Whistleblower Policy") that set forth procedures by which Covered Persons (as defined in the Whistleblower Policy) may raise, on a confidential basis, concerns regarding, among other things, any questionable or unethical accounting, internal accounting controls or auditing matters with the Audit Committee. Third parties, such as our clients, stockholders or competitors may also report a good faith complaint regarding such matters.
|
•
|
We have an insider trading policy that prohibits any of our directors or employees, partners, directors and officers of Apollo, as well as others, from buying or selling our securities on the basis of material nonpublic information.
|
Item 1A.
|
Risk Factors.
|
•
|
the issuer issues securities, the payment of which depends primarily on the cash flow from "eligible assets," which are assets that by their terms convert into cash within a finite time period;
|
•
|
the securities sold are fixed-income securities rated investment grade by at least one rating agency except that fixed- income securities which are unrated or rated below investment grade may be sold to institutional accredited investors and any securities may be sold to "qualified institutional buyers" and to persons involved in the organization or operation of the issuer;
|
•
|
the issuer acquires and disposes of eligible assets (1) only in accordance with the agreements pursuant to which the securities are issued and (2) so that the acquisition or disposition does not result in a downgrading of the issuer’s fixed-income securities and (3) the primary purpose of which is not recognizing gains or decreasing losses resulting from market value changes; and
|
•
|
unless the issuer is issuing only commercial paper, the issuer appoints an independent trustee, takes reasonable steps to transfer to the trustee an ownership or perfected security interest in the eligible assets, and meets rating agency requirements for commingling of cash flows.
|
•
|
actual receipt of an improper benefit or profit in money, property or services; or
|
•
|
active and deliberate dishonesty by the director or officer that was established by a final judgment and was material to the cause of action adjudicated.
|
•
|
general market conditions;
|
•
|
the market’s view of the quality of our assets;
|
•
|
the market’s perception of our growth potential;
|
•
|
our eligibility to participate in and access capital from programs established by the U.S. government;
|
•
|
our current and potential future earnings and cash distributions; and
|
•
|
the market price of the shares of our common stock.
|
•
|
our cash flow from operations may be insufficient to make required payments of principal of and interest on the debt or we may fail to comply with all of the other covenants contained in the debt documents, which is likely to result in (i) acceleration of such debt (and any other debt containing a cross-default or cross-acceleration provision) that we may be unable to repay from internal funds or to refinance on favorable terms, or at all, (ii) our inability to borrow unused amounts under our financing arrangements, even if we are current in payments on borrowings under those arrangements and/or (iii) the loss of some or all of our assets to foreclosure or sale;
|
•
|
our debt may increase our vulnerability to adverse economic and industry conditions with no assurance that investment yields will increase with higher financing costs;
|
•
|
we may be required to dedicate a substantial portion of our cash flow from operations to payments on our debt, thereby reducing funds available for operations, future business opportunities, stockholder distributions or other purposes; and
|
•
|
we may not be able to refinance debt that matures prior to the investment it was used to finance on favorable terms, or at all.
|
•
|
risks of delinquency and foreclosure, and risks of loss in the event thereof;
|
•
|
the dependence upon the successful operation of, and net income from, real property;
|
•
|
risks generally incident to interests in real property; and
|
•
|
risks specific to the type and use of a particular property.
|
•
|
acts of God, including earthquakes, floods and other natural disasters, which may result in uninsured losses;
|
•
|
acts of war or terrorism, including the consequences of terrorist attacks;
|
•
|
adverse changes in national and local economic and market conditions;
|
•
|
changes in governmental laws and regulations, fiscal policies and zoning ordinances and the related costs of compliance with laws and regulations, fiscal policies and ordinances;
|
•
|
costs of remediation and liabilities associated with environmental conditions such as indoor mold; and
|
•
|
the potential for uninsured or under-insured property losses.
|
Item 1B.
|
Unresolved Staff Comments.
|
Item 2.
|
Properties.
|
Item 3.
|
Legal Proceedings.
|
Item 4.
|
Mine Safety Disclosures.
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|
|
Period Ending
|
|||||
|
12/31/14
|
12/31/15
|
12/31/16
|
12/31/17
|
12/31/18
|
12/31/19
|
Apollo Commercial Real Estate Finance, Inc.
|
100.00
|
116.20
|
124.49
|
151.98
|
151.87
|
183.97
|
S&P 500
|
100.00
|
101.25
|
113.40
|
138.01
|
131.72
|
172.85
|
BBREMTG Index
|
100.00
|
90.74
|
109.97
|
131.86
|
128.03
|
158.27
|
Plan Category
|
Number of
securities to
be issued upon
exercise of
outstanding options,
warrants and rights
|
|
Weighted-average
exercise price of
outstanding options,
warrants and rights
|
|
Number of securities
remaining available
for future issuance
under equity
compensation plans
(excluding securities
reflected in the first
column of this table)
|
||||
Equity compensation plans approved by stockholders
|
—
|
|
|
$
|
—
|
|
|
5,930,798
|
|
Equity compensation plans not approved by stockholders
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
—
|
|
|
$
|
—
|
|
|
5,930,798
|
|
Item 6.
|
Selected Financial Data.
|
|
For the Year Ended December 31,
|
||||||||||||||||||
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
Operating Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest income
|
$
|
487,408
|
|
|
$
|
403,889
|
|
|
$
|
338,521
|
|
|
$
|
264,376
|
|
|
$
|
192,164
|
|
Interest expense
|
(152,926
|
)
|
|
(114,597
|
)
|
|
(78,057
|
)
|
|
(63,759
|
)
|
|
(48,861
|
)
|
|||||
Net interest income
|
334,482
|
|
|
289,292
|
|
|
260,464
|
|
|
200,617
|
|
|
143,303
|
|
|||||
Operating expenses
|
(64,831
|
)
|
|
(56,894
|
)
|
|
(52,377
|
)
|
|
(48,371
|
)
|
|
(26,111
|
)
|
|||||
Income (loss) from unconsolidated joint venture
|
—
|
|
|
—
|
|
|
(2,847
|
)
|
|
(96
|
)
|
|
3,464
|
|
|||||
Other income
|
2,113
|
|
|
1,438
|
|
|
940
|
|
|
1,094
|
|
|
1,239
|
|
|||||
Provision for loan losses and impairments, net of reversals
|
(20,000
|
)
|
|
(20,000
|
)
|
|
(5,000
|
)
|
|
(15,000
|
)
|
|
—
|
|
|||||
Realized gain (loss) on investments
|
(12,513
|
)
|
|
—
|
|
|
(42,693
|
)
|
|
3,834
|
|
|
(443
|
)
|
|||||
Unrealized gain (loss) on securities
|
—
|
|
|
—
|
|
|
37,165
|
|
|
(26,099
|
)
|
|
(17,408
|
)
|
|||||
Foreign currency gain (loss)
|
19,818
|
|
|
(30,335
|
)
|
|
18,506
|
|
|
(29,284
|
)
|
|
(4,894
|
)
|
|||||
Bargain purchase gain
|
—
|
|
|
—
|
|
|
—
|
|
|
40,021
|
|
|
—
|
|
|||||
Loss on early extinguishment of debt
|
—
|
|
|
(2,573
|
)
|
|
(1,947
|
)
|
|
—
|
|
|
—
|
|
|||||
Gain (loss) on foreign currency forwards
|
(14,425
|
)
|
|
39,058
|
|
|
(19,180
|
)
|
|
31,160
|
|
|
4,106
|
|
|||||
Unrealized loss on interest rate swap
|
(14,470
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net income
|
230,174
|
|
|
219,986
|
|
|
193,031
|
|
|
157,876
|
|
|
103,256
|
|
|||||
Preferred dividends
|
(18,525
|
)
|
|
(27,340
|
)
|
|
(36,761
|
)
|
|
(30,295
|
)
|
|
(11,884
|
)
|
|||||
Net income available to common stockholders
|
211,649
|
|
|
192,646
|
|
|
156,270
|
|
|
127,581
|
|
|
91,372
|
|
|||||
Net income per share of common stock:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
$
|
1.41
|
|
|
$
|
1.52
|
|
|
$
|
1.54
|
|
|
$
|
1.74
|
|
|
$
|
1.54
|
|
Diluted
|
$
|
1.40
|
|
|
$
|
1.48
|
|
|
$
|
1.54
|
|
|
$
|
1.74
|
|
|
$
|
1.54
|
|
Dividends declared per share of common stock
|
$
|
1.84
|
|
|
$
|
1.84
|
|
|
$
|
1.84
|
|
|
$
|
1.84
|
|
|
$
|
1.78
|
|
Balance Sheet Data (at period end):
|
|
|
|
|
|
|
|
|
|
||||||||||
Total assets
|
$
|
6,888,363
|
|
|
$
|
5,095,819
|
|
|
$
|
4,088,605
|
|
|
$
|
3,482,977
|
|
|
$
|
2,712,590
|
|
Total liabilities
|
4,258,388
|
|
|
2,586,072
|
|
|
2,000,462
|
|
|
1,550,750
|
|
|
1,337,166
|
|
|||||
Total stockholders’ equity
|
2,629,975
|
|
|
2,509,747
|
|
|
2,088,143
|
|
|
1,932,227
|
|
|
1,375,424
|
|
Description
|
|
Amortized
Cost |
|
Weighted- Average Coupon (1)
|
|
Weighted- Average All-in Yield (1)(2)
|
|
Secured Debt (3)
|
|
Cost of Funds
|
|
Equity at
cost(4) |
|||||||||
Commercial mortgage loans, net
|
|
$
|
5,326,967
|
|
|
5.3
|
%
|
|
6.0
|
%
|
|
$
|
3,095,556
|
|
|
3.3
|
%
|
|
$
|
2,231,411
|
|
Subordinate loans and other lending assets, net
|
|
1,048,126
|
|
|
12.8
|
%
|
|
14.1
|
%
|
|
—
|
|
|
—
|
|
|
1,048,126
|
|
|||
Total/Weighted-Average
|
|
$
|
6,375,093
|
|
|
6.5
|
%
|
|
7.4
|
%
|
|
$
|
3,095,556
|
|
|
3.3
|
%
|
|
$
|
3,279,537
|
|
(1)
|
Weighted-Average Coupon and Weighted-Average All-in Yield are based on the applicable benchmark rates as of December 31, 2019 on the floating rate loans.
|
(2)
|
Weighted-Average All-in Yield includes the amortization of deferred origination fees, loan origination costs and accrual of both extension and exit fees. Yield excludes the benefit of forward points on currency hedges related to loans denominated in currencies other than USD.
|
(3)
|
Gross of deferred financing costs of $17.2 million.
|
(4)
|
Represents loan portfolio at amortized cost less secured debt outstanding.
|
Urban Predevelopment
|
4
|
01/2016
|
183
|
—
|
|
09/2021
|
Miami, FL
|
Office
|
3
|
11/2017
|
161
|
—
|
|
01/2023
|
Chicago, IL
|
Urban Predevelopment
|
3
|
03/2017
|
154
|
11
|
|
12/2020
|
Brooklyn, NY
|
Hotel
|
3
|
04/2018
|
151
|
2
|
|
04/2023
|
Honolulu, HI
|
Hotel (1)
|
3
|
09/2015
|
140
|
—
|
|
06/2023
|
Manhattan, NY
|
Hotel
|
3
|
05/2018
|
139
|
—
|
|
06/2023
|
Miami, FL
|
Hotel
|
3
|
08/2019
|
133
|
—
|
|
08/2024
|
Puglia, Italy
|
Residential-for-sale: inventory
|
2
|
03/2018
|
130
|
—
|
|
03/2021
|
London, UK
|
Office
|
3
|
01/2018
|
127
|
62
|
|
01/2022
|
Renton, WA
|
Retail center (3)
|
5
|
11/2014
|
125
|
—
|
|
09/2020
|
Cincinnati, OH
|
Office
|
3
|
10/2018
|
112
|
74
|
Y
|
10/2023
|
Manhattan, NY
|
Residential-for-sale: construction
|
3
|
12/2019
|
107
|
42
|
Y
|
01/2023
|
Boston, MA
|
Hotel
|
3
|
03/2017
|
105
|
—
|
|
03/2022
|
Atlanta, GA
|
Hotel
|
3
|
11/2018
|
99
|
—
|
|
12/2023
|
Vail, CO
|
Hotel
|
3
|
12/2017
|
89
|
—
|
|
12/2022
|
Manhattan, NY
|
Hotel
|
3
|
07/2018
|
87
|
—
|
|
08/2021
|
Detroit, MI
|
Office
|
3
|
03/2018
|
84
|
7
|
|
04/2023
|
Chicago, IL
|
Residential-for-sale: inventory
|
3
|
12/2019
|
82
|
—
|
|
07/2021
|
Manhattan, NY
|
Office
|
3
|
12/2017
|
79
|
48
|
|
07/2022
|
London, UK
|
Mixed Use
|
3
|
12/2019
|
76
|
2
|
|
12/2024
|
London, UK
|
Mixed Use
|
3
|
12/2019
|
73
|
896
|
Y
|
06/2025
|
London, UK
|
Urban Predevelopment
|
3
|
12/2016
|
73
|
—
|
|
06/2020
|
Los Angeles, CA
|
Residential-for-sale: construction
|
3
|
12/2018
|
70
|
107
|
Y
|
12/2023
|
Manhattan, NY
|
Multifamily
|
3
|
04/2014
|
70
|
—
|
|
07/2023
|
Various
|
Hotel
|
3
|
08/2019
|
67
|
—
|
|
09/2022
|
Manhattan, NY
|
Office
|
3
|
04/2019
|
65
|
95
|
Y
|
09/2025
|
Culver City, CA
|
Hotel
|
3
|
04/2018
|
63
|
—
|
|
05/2023
|
Scottsdale, AZ
|
Hotel
|
3
|
09/2019
|
60
|
—
|
|
10/2024
|
Miami, FL
|
Hotel
|
3
|
12/2019
|
59
|
—
|
|
01/2025
|
Tucson, AZ
|
Multifamily
|
3
|
11/2014
|
54
|
—
|
|
11/2021
|
Various
|
Residential-for-sale: construction
|
3
|
01/2018
|
53
|
27
|
Y
|
01/2023
|
Manhattan, NY
|
Hotel
|
3
|
05/2019
|
52
|
—
|
|
06/2024
|
Chicago, IL
|
Multifamily
|
2
|
06/2018
|
50
|
—
|
|
06/2020
|
London, UK
|
Hotel
|
3
|
12/2015
|
42
|
—
|
|
08/2024
|
St. Thomas, USVI
|
Hotel
|
3
|
02/2018
|
38
|
—
|
|
03/2023
|
Pittsburgh, PA
|
Residential-for-sale: inventory
|
2
|
06/2018
|
38
|
—
|
|
06/2020
|
Manhattan, NY
|
Office
|
3
|
04/2019
|
31
|
45
|
Y
|
08/2022
|
Birmingham, UK
|
Office
|
3
|
12/2019
|
31
|
6
|
|
12/2022
|
Edinburgh, Scotland
|
Office
|
3
|
08/2018
|
27
|
175
|
Y
|
12/2022
|
London, UK
|
Residential-for-sale: construction
|
3
|
12/2018
|
27
|
75
|
Y
|
01/2024
|
Hallandale Beach, FL
|
Residential-for-sale: inventory
|
2
|
05/2018
|
24
|
—
|
|
04/2021
|
Manhattan, NY
|
Residential-for-sale: construction
|
3
|
03/2018
|
13
|
101
|
Y
|
03/2023
|
San Francisco, CA
|
Residential-for-sale: inventory (3)
|
5
|
02/2014
|
12
|
—
|
|
04/2020
|
Bethesda, MD
|
Sub-total / Weighted-Average Commercial Mortgage Loans
|
3.0
|
|
$5,327
|
$1,908
|
11%
|
3.4 Years
|
|
Subordinate Loan and Other Lending Assets Portfolio
|
|||||||
Property Type
|
Risk Rating
|
Origination Date
|
Amortized Cost
|
Unfunded Commitment
|
Construction Loan (4)
|
Fully-extended Maturity
|
Location
|
Residential-for-sale: construction (2)
|
3
|
06/2015
|
$210
|
$—
|
Y
|
02/2021
|
Manhattan, NY
|
Office
|
3
|
01/2019
|
99
|
—
|
|
12/2025
|
Manhattan, NY
|
Residential-for-sale: construction
|
3
|
12/2017
|
97
|
17
|
Y
|
06/2022
|
Manhattan, NY
|
Healthcare
|
3
|
01/2019
|
93
|
—
|
|
01/2024
|
Various
|
Multifamily
|
3
|
10/2015
|
68
|
—
|
|
03/2020
|
Manhattan, NY
|
Residential-for-sale: construction
|
3
|
12/2017
|
66
|
—
|
Y
|
04/2023
|
Los Angeles, CA
|
Healthcare
|
3
|
07/2019
|
51
|
—
|
|
06/2024
|
Various
|
Residential-for-sale: construction (2)
|
3
|
11/2017
|
51
|
—
|
Y
|
02/2021
|
Manhattan, NY
|
Mixed Use
|
3
|
01/2017
|
42
|
—
|
|
02/2027
|
Cleveland, OH
|
Mixed Use
|
3
|
02/2019
|
39
|
—
|
Y
|
12/2022
|
London, UK
|
Residential-for-sale: inventory
|
2
|
10/2016
|
36
|
—
|
|
10/2020
|
Manhattan, NY
|
Industrial
|
2
|
05/2013
|
32
|
—
|
|
05/2023
|
Various
|
Hotel
|
2
|
06/2015
|
24
|
—
|
|
07/2025
|
Phoenix, AZ
|
Mixed Use
|
3
|
12/2018
|
24
|
28
|
Y
|
12/2023
|
Brooklyn, NY
|
Hotel
|
3
|
06/2015
|
20
|
—
|
|
12/2022
|
Washington, DC
|
Hotel
|
3
|
06/2018
|
20
|
—
|
|
06/2023
|
Las Vegas, NV
|
Hotel (1)
|
3
|
09/2015
|
20
|
—
|
|
06/2023
|
Manhattan, NY
|
Multifamily
|
3
|
05/2018
|
19
|
—
|
|
05/2028
|
Cleveland, OH
|
Office
|
2
|
07/2013
|
14
|
—
|
|
07/2022
|
Manhattan, NY
|
Hotel
|
3
|
05/2017
|
8
|
—
|
|
06/2027
|
Anaheim, CA
|
Office
|
3
|
08/2017
|
8
|
—
|
|
09/2024
|
Troy, MI
|
Mixed Use
|
3
|
07/2012
|
7
|
—
|
|
08/2022
|
Chapel Hill, NC
|
Sub-total / Weighted-Average Subordinate Loans and Other Lending Assets
|
2.9
|
|
$1,048
|
$45
|
46%
|
3.1 Years
|
|
|
|
|
|
|
|
|
|
Total / Weighted-Average Loan Portfolio
|
3.0
|
|
$6,375
|
$1,953
|
17%
|
3.3 Years
|
|
(1)
|
Both loans are secured by the same property.
|
(2)
|
Both loans are secured by the same property.
|
(3)
|
Amortized cost for these loans is net of the recorded provisions for loan losses and impairments.
|
(4)
|
Weighted-average construction loan % is based on the amortized cost of the loans.
|
Property Type
|
Security
|
Location
|
Date of Origination
|
First Date of Loss
|
Maximum Principal Funded
|
Amortized Cost
|
Loss
|
Type
|
Retail Center
|
Mortgage
|
Cincinnati, OH
|
11/2014
|
12/2018
|
$171,215
|
$124,609
|
$47,000
|
Unrealized
|
Residential-for-sale: inventory
|
Mortgage
|
Bethesda, MD
|
2/2014
|
6/2017
|
80,000
|
11,695
|
13,000
|
Unrealized
|
Multifamily
|
Mortgage
|
Williston, ND
|
11/2014
|
6/2016
|
58,000
|
—
|
12,513
|
Realized
|
Total
|
|
|
|
|
$309,215
|
$136,304
|
$72,513
|
|
|
|
Average month-end balances for the year ended December 31, 2019
|
||||||
Description
|
|
Assets
|
|
Related debt
|
||||
Commercial mortgage loans, net
|
|
$
|
4,489,189
|
|
|
$
|
2,326,062
|
|
Subordinate loans and other lending assets, net
|
|
1,234,910
|
|
|
—
|
|
|
Year ended December 31,
|
|
2019 vs. 2018
|
||||||||
|
2019
|
|
2018
|
|
$
|
||||||
Net interest income:
|
|
|
|
|
|
||||||
Interest income from commercial mortgage loans
|
$
|
322,475
|
|
|
$
|
263,709
|
|
|
$
|
58,766
|
|
Interest income from subordinate loans and other lending assets
|
164,933
|
|
|
140,180
|
|
|
24,753
|
|
|||
Interest expense
|
(152,926
|
)
|
|
(114,597
|
)
|
|
(38,329
|
)
|
|||
Net interest income
|
334,482
|
|
|
289,292
|
|
|
45,190
|
|
|||
Operating expenses:
|
|
|
|
|
|
||||||
General and administrative expenses
|
(24,097
|
)
|
|
(20,470
|
)
|
|
(3,627
|
)
|
|||
Management fees to related party
|
(40,734
|
)
|
|
(36,424
|
)
|
|
(4,310
|
)
|
|||
Total operating expenses
|
(64,831
|
)
|
|
(56,894
|
)
|
|
(7,937
|
)
|
|||
Other income
|
2,113
|
|
|
1,438
|
|
|
675
|
|
|||
Provision for loan losses and impairments, net of reversals
|
(20,000
|
)
|
|
(20,000
|
)
|
|
—
|
|
|||
Realized loss on investments
|
(12,513
|
)
|
|
—
|
|
|
(12,513
|
)
|
|||
Foreign currency gain (loss)
|
19,818
|
|
|
(30,335
|
)
|
|
50,153
|
|
|||
Loss on early extinguishment of debt
|
—
|
|
|
(2,573
|
)
|
|
2,573
|
|
|||
Gain (loss) on foreign currency forwards
|
(14,425
|
)
|
|
39,058
|
|
|
(53,483
|
)
|
|||
Unrealized loss on interest rate swap
|
(14,470
|
)
|
|
—
|
|
|
(14,470
|
)
|
|||
Net income
|
$
|
230,174
|
|
|
$
|
219,986
|
|
|
$
|
10,188
|
|
Dividends declared per share of:
|
2019
|
|
2018
|
Common Stock (1)
|
$1.84
|
|
$1.84
|
Series B Preferred Stock
|
2.00
|
|
2.00
|
Series C Preferred Stock (2)
|
0.72
|
|
2.00
|
(1)
|
As our aggregate 2019 distributions exceeded our earnings and profits, $0.46 of the January 2020 distribution declared in the fourth quarter of 2019 are payable to common stockholders of record as of December 31, 2019 will be treated as a 2020 distribution for U.S. federal income tax purposes.
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||||
Risk Rating
|
|
Number of Loans
|
|
Carrying Value
|
|
% of Loan Portfolio
|
|
Number of Loans
|
|
Carrying Value
|
|
% of Loan Portfolio
|
||||||
1
|
|
—
|
|
$
|
—
|
|
|
—
|
%
|
|
—
|
|
$
|
—
|
|
|
—
|
%
|
2
|
|
8
|
|
348,324
|
|
|
5
|
%
|
|
3
|
|
138,040
|
|
|
3
|
%
|
||
3
|
|
61
|
|
5,707,555
|
|
|
90
|
%
|
|
63
|
|
4,573,930
|
|
|
93
|
%
|
||
4
|
|
1
|
|
182,910
|
|
|
3
|
%
|
|
—
|
|
—
|
|
|
—
|
%
|
||
5
|
|
2
|
|
136,304
|
|
|
2
|
%
|
|
3
|
|
215,623
|
|
|
4
|
%
|
||
|
|
72
|
|
$
|
6,375,093
|
|
|
100
|
%
|
|
69
|
|
$
|
4,927,593
|
|
|
100
|
%
|
|
December 31, 2019
|
|
December 31, 2018
|
Debt to Equity Ratio (1)
|
1.4x
|
|
0.9x
|
(1)
|
Represents total debt less cash and loan proceeds held by servicer to total stockholders' equity.
|
•
|
no investment will be made that would cause us to fail to qualify as a REIT for U.S. federal income tax purposes;
|
•
|
no investment will be made that would cause us to register as an investment company under the 1940 Act;
|
•
|
investments will be predominantly in our target assets;
|
•
|
no more than 20% of our cash equity (on a consolidated basis) will be invested in any single investment at the time of the investment; and
|
•
|
until appropriate investments can be identified, the Manager may invest the proceeds of any offering in interest bearing, short-term investments, including money market accounts and/or funds, that are consistent with our intention to qualify as a REIT.
|
|
Less than 1
year (3) |
|
1 to 3
years (3) |
|
3 to 5
years (3) |
|
More
than 5 years (3) |
|
Total
|
||||||||||
Secured debt arrangements, net (1) (2)
|
$
|
852,488
|
|
|
$
|
1,307,733
|
|
|
$
|
1,168,384
|
|
|
$
|
—
|
|
|
$
|
3,328,605
|
|
Convertible senior notes, net (2)
|
28,750
|
|
|
396,825
|
|
|
240,302
|
|
|
—
|
|
|
665,877
|
|
|||||
Senior secured term loan, net (2)
|
27,622
|
|
|
54,438
|
|
|
80,009
|
|
|
475,306
|
|
|
637,375
|
|
|||||
Unfunded loan commitments (3)
|
861,087
|
|
|
872,449
|
|
|
219,351
|
|
|
—
|
|
|
1,952,887
|
|
|||||
Total
|
$
|
1,769,947
|
|
|
$
|
2,631,445
|
|
|
$
|
1,708,046
|
|
|
$
|
475,306
|
|
|
$
|
6,584,744
|
|
(1)
|
Assumes underlying assets are financed through the fully extended maturity date of the facility.
|
(2)
|
Based on the applicable benchmark rates as of December 31, 2019 on the floating rate debt for interest payments due.
|
(3)
|
Based on our expected funding schedule, which is based upon the Manager’s estimates based upon the best information available to the Manager at the time. There is no assurance that the payments will occur in accordance with these estimates or at all, which could affect our operating results.
|
(1)
|
This reconciliation only applies to the years ended December 31, 2019 and 2018 because in reporting periods prior to 2018, the treasury stock method was used when determining the potential share dilution from the Notes in the computation of earnings per share.
|
(2)
|
Face and Price represent the weighted-average balances during the period.
|
(3)
|
The 2023 Notes were issued on October 5, 2018, however the weighted-average of the potentially issuable shares due to conversion are taken over the full year.
|
|
Year ended December 31,
|
||||||
|
2019
|
|
2018
|
||||
Net income available to common stockholders
|
$
|
211,649
|
|
|
$
|
192,646
|
|
Adjustments:
|
|
|
|
||||
Equity-based compensation expense
|
15,897
|
|
|
13,588
|
|
||
Unrealized loss on interest rate swap
|
14,470
|
|
|
—
|
|
||
(Gain) loss on foreign currency forwards
|
14,425
|
|
|
(39,058
|
)
|
||
Foreign currency (gain) loss, net
|
(19,818
|
)
|
|
30,335
|
|
||
Realized gains relating to interest income on foreign currency hedges, net(1)
|
1,904
|
|
|
867
|
|
||
Realized gains relating to forward points on foreign currency hedges, net
|
6,789
|
|
|
1,068
|
|
||
Amortization of the convertible senior notes related to equity reclassification
|
3,105
|
|
|
3,958
|
|
||
Provision for loan losses and impairments, net of reversals
|
20,000
|
|
|
20,000
|
|
||
Total adjustments:
|
56,772
|
|
|
30,758
|
|
||
Operating Earnings
|
$
|
268,421
|
|
|
$
|
223,404
|
|
|
|
|
|
||||
Realized loss on investments
|
12,513
|
|
|
—
|
|
||
Loss on early extinguishment of debt
|
—
|
|
|
2,573
|
|
||
Operating Earnings excluding realized loss on investments and loss on early extinguishment of debt
|
$
|
280,934
|
|
|
$
|
225,977
|
|
Diluted Operating Earnings per Share of Common Stock(2)
|
$
|
1.80
|
|
|
$
|
1.78
|
|
Diluted Operating Earnings excluding realized loss on investments and loss on early extinguishment of debt(2)
|
$
|
1.89
|
|
|
$
|
1.80
|
|
Basic weighted-average shares of common stock outstanding
|
146,881,231
|
|
|
124,147,073
|
|
||
Weighted-average diluted shares - Operating Earnings
|
148,717,441
|
|
|
125,759,749
|
|
(1)
|
In order to conform to the 2019 presentation of the reconciliation from net income available to common stockholders to Operating Earnings, $0.9 million was reclassified from net realized gains relating to interest and forward points on foreign currency hedges, net for the year ended December 31, 2018.
|
(2)
|
For the computation of diluted Operating Earnings per share of common stock, for the years ended December 31, 2019 and 2018, $32.2 million and $33.5 million, respectively, of interest expense related to the Notes is not deducted from the numerator and the potentially dilutive shares related to the Notes are excluded from the denominator.
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Stockholders' Equity
|
$
|
2,629,975
|
|
|
$
|
2,509,747
|
|
Series B Preferred Stock (Liquidation Preference)
|
(169,260
|
)
|
|
(169,260
|
)
|
||
Series C Preferred Stock (Liquidation Preference)
|
—
|
|
|
(172,500
|
)
|
||
Common Stockholders' Equity
|
$
|
2,460,715
|
|
|
$
|
2,167,987
|
|
Common Stock
|
153,537,296
|
|
|
133,853,565
|
|
||
Book value per share
|
$
|
16.03
|
|
|
$
|
16.20
|
|
|
Book value per share
|
||
Book value per share at December 31, 2018
|
$
|
16.20
|
|
Vesting and issuance of common stock under the LTIPs
|
(0.09
|
)
|
|
Shares issued related to the conversion of the 2019 Notes
|
0.01
|
|
|
Other
|
0.01
|
|
|
Book value per share at March 31, 2019
|
$
|
16.13
|
|
Common stock offering, net of subsequent dividend
|
0.20
|
|
|
Reversal of loan losses and impairments
|
0.02
|
|
|
Gain on foreign currency forwards, net
|
0.02
|
|
|
Unrealized loss on interest rate swap
|
(0.08
|
)
|
|
Other
|
0.01
|
|
|
Book value per share at June 30, 2019
|
$
|
16.30
|
|
Provision for loan losses and impairments
|
(0.22
|
)
|
|
Unrealized loss on interest rate swap
|
(0.07
|
)
|
|
Other
|
0.01
|
|
|
Book value per share at September 30, 2019
|
$
|
16.02
|
|
Other
|
0.01
|
|
|
Book value per share at December 31, 2019
|
$
|
16.03
|
|
|
Book value per share
|
||
Book value per share at December 31, 2018
|
$
|
16.20
|
|
Provision for loan losses and impairments, net of reversal
|
(0.22
|
)
|
|
Unrealized loss on interest rate swap
|
(0.15
|
)
|
|
Vesting and issuance of common stock under the LTIPs
|
(0.09
|
)
|
|
Common stock offering, net of subsequent dividend
|
0.20
|
|
|
Other
|
0.04
|
|
|
Gain on foreign currency forwards, net
|
0.02
|
|
|
Reversal of loan losses and impairments
|
0.02
|
|
|
Shares issued related to the conversion of the 2019 Notes
|
0.01
|
|
|
Book value per share at December 31, 2019
|
$
|
16.03
|
|
•
|
attempting to structure our financing agreements to have a range of different maturities, terms, amortizations and interest rate adjustment periods;
|
•
|
using hedging instruments, interest rate swaps; and
|
•
|
to the extent available, using securitization financing to better match the maturity of our financing with the duration of our assets.
|
|
|
|
|
50 basis point increase
|
|
50 basis point decrease
|
||||||||||||||
Currency
|
|
Net floating rate assets subject to interest rate sensitivity
|
|
Increase to net interest income (1)(2)
|
|
Increase to net interest income (per share) (1)(2)
|
|
Decrease to net interest income(1) (2)
|
|
Decrease to net interest income (per share)(1) (2)
|
||||||||||
USD
|
|
$
|
1,687,107
|
|
|
$
|
5,237
|
|
|
$
|
0.03
|
|
|
$
|
(8
|
)
|
|
$
|
—
|
|
GBP
|
|
826,631
|
|
|
4,100
|
|
|
0.03
|
|
|
(2,346
|
)
|
|
(0.02
|
)
|
|||||
EUR
|
|
140,648
|
|
|
121
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total:
|
|
$
|
2,654,386
|
|
|
$
|
9,458
|
|
|
$
|
0.06
|
|
|
$
|
(2,354
|
)
|
|
$
|
(0.02
|
)
|
Item 8.
|
Financial Statements and Supplementary Data.
|
Schedule
|
|
•
|
We tested the effectiveness of controls over management’s identification of possible impairment indicators, and controls over management’s review of the fair value analysis including controls over management’s review of the selection of the discount rate and the inputs used within the fair value analysis. These inputs include, but are not limited to, debt service coverage ratio, occupancy, capitalization rate, and microeconomic and macroeconomic conditions that could impact the property.
|
•
|
We evaluated the Company’s assessment of impairment indicators by:
|
–
|
Evaluating the accuracy and determining the relevance of the asset-specific factors utilized during the Company’s evaluation
|
–
|
Evaluating the period changes on items such as debt yield, occupancy, cash flow volatility, leasing and tenant profile, loan structure, exit plan, project sponsorship, and changes in budgets by (1) evaluating the source information and assumptions used by management and (2) testing the mathematical accuracy of the Company’s analysis.
|
–
|
Evaluating the financial performance of the collateral associated with each loan
|
–
|
Reviewing summaries of third-party reports, where applicable
|
–
|
Evaluating the impact of macroeconomic and microeconomic events on the borrower, sponsor, or asset type
|
–
|
Reviewing the remittance for all loans in the Company’s portfolio to corroborate that the borrowers had the ability to pay their current obligations on the loan
|
•
|
We evaluated the Company’s determination of fair value for those assets with impairment indicators by performing the following:
|
–
|
With the assistance of our fair value specialists, we evaluated the reasonableness of the (1) valuation methodology; (2) significant assumptions made, including whether the significant inputs used in the model were appropriate and consistent with what market participants would use to value the collateral; and (3) mathematical accuracy of the overall valuation model
|
–
|
Testing the underlying data used to develop the fair value to determine that the information used in the analysis was accurate and complete
|
–
|
Performing a sensitivity analysis when deemed necessary based on results of other audit procedures performed for comparison to the Company’s fair value analysis
|
–
|
Considering whether events or transactions that occurred after the balance sheet date but before the completion of the audit affect the conclusions reached on the fair value measures and disclosures
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
452,282
|
|
|
$
|
109,806
|
|
Commercial mortgage loans, net (includes $4,852,087 and $3,197,900 pledged as collateral under secured debt arrangements in 2019 and 2018, respectively)
|
5,326,967
|
|
|
3,878,981
|
|
||
Subordinate loans and other lending assets, net
|
1,048,126
|
|
|
1,048,612
|
|
||
Other assets
|
52,716
|
|
|
33,720
|
|
||
Loan proceeds held by servicer
|
8,272
|
|
|
1,000
|
|
||
Derivative assets, net
|
—
|
|
|
23,700
|
|
||
Total Assets
|
$
|
6,888,363
|
|
|
$
|
5,095,819
|
|
Liabilities and Stockholders' Equity
|
|
|
|
||||
Liabilities:
|
|
|
|
||||
Secured debt arrangements, net (net of deferred financing costs of $17,190 and $17,555 in 2019 and 2018, respectively)
|
$
|
3,078,366
|
|
|
$
|
1,879,522
|
|
Convertible senior notes, net
|
561,573
|
|
|
592,000
|
|
||
Senior secured term loan, net (net of deferred financing costs of $7,277 and $0 in 2019 and 2018, respectively)
|
487,961
|
|
|
—
|
|
||
Accounts payable, accrued expenses and other liabilities
|
100,712
|
|
|
104,746
|
|
||
Derivative liabilities, net
|
19,346
|
|
|
—
|
|
||
Payable to related party
|
10,430
|
|
|
9,804
|
|
||
Total Liabilities
|
4,258,388
|
|
|
2,586,072
|
|
||
Commitments and Contingencies (see Note 15)
|
|
|
|
|
|
||
Stockholders’ Equity:
|
|
|
|
||||
Preferred stock, $0.01 par value, 50,000,000 shares authorized:
|
|
|
|
||||
Series B preferred stock, 6,770,393 shares issued and outstanding ($169,260 liquidation preference)
|
68
|
|
|
68
|
|
||
Series C preferred stock, 0 and 6,900,000 shares issued and outstanding ($0 and $172,500 liquidation preference) in 2019 and 2018, respectively
|
—
|
|
|
69
|
|
||
Common stock, $0.01 par value, 450,000,000 shares authorized, 153,537,296 and 133,853,565 shares issued and outstanding in 2019 and 2018, respectively
|
1,535
|
|
|
1,339
|
|
||
Additional paid-in-capital
|
2,825,317
|
|
|
2,638,441
|
|
||
Accumulated deficit
|
(196,945
|
)
|
|
(130,170
|
)
|
||
Total Stockholders’ Equity
|
2,629,975
|
|
|
2,509,747
|
|
||
Total Liabilities and Stockholders’ Equity
|
$
|
6,888,363
|
|
|
$
|
5,095,819
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Net interest income:
|
|
|
|
|
|
||||||
Interest income from commercial mortgage loans
|
$
|
322,475
|
|
|
$
|
263,709
|
|
|
$
|
158,632
|
|
Interest income from subordinate loans and other lending assets
|
164,933
|
|
|
140,180
|
|
|
179,889
|
|
|||
Interest expense
|
(152,926
|
)
|
|
(114,597
|
)
|
|
(78,057
|
)
|
|||
Net interest income
|
334,482
|
|
|
289,292
|
|
|
260,464
|
|
|||
Operating expenses:
|
|
|
|
|
|
||||||
General and administrative expenses (includes equity-based compensation of $15,897 in 2019, $13,588 in 2018, and $13,314 in 2017)
|
(24,097
|
)
|
|
(20,470
|
)
|
|
(20,725
|
)
|
|||
Management fees to related party
|
(40,734
|
)
|
|
(36,424
|
)
|
|
(31,652
|
)
|
|||
Total operating expenses
|
(64,831
|
)
|
|
(56,894
|
)
|
|
(52,377
|
)
|
|||
Loss from unconsolidated joint venture
|
—
|
|
|
—
|
|
|
(2,847
|
)
|
|||
Other income
|
2,113
|
|
|
1,438
|
|
|
940
|
|
|||
Provision for loan losses and impairments, net of reversals
|
(20,000
|
)
|
|
(20,000
|
)
|
|
(5,000
|
)
|
|||
Realized loss on investments
|
(12,513
|
)
|
|
—
|
|
|
(42,693
|
)
|
|||
Unrealized gain on securities
|
—
|
|
|
—
|
|
|
37,165
|
|
|||
Foreign currency gain (loss)
|
19,818
|
|
|
(30,335
|
)
|
|
18,506
|
|
|||
Loss on early extinguishment of debt
|
—
|
|
|
(2,573
|
)
|
|
(1,947
|
)
|
|||
Gain (loss) on foreign currency forwards (includes unrealized gains (losses) of $(28,576) in 2019, $29,345 in 2018, and $(11,523) in 2017)
|
(14,425
|
)
|
|
39,058
|
|
|
(19,180
|
)
|
|||
Unrealized loss on interest rate swap
|
(14,470
|
)
|
|
—
|
|
|
—
|
|
|||
Net income
|
$
|
230,174
|
|
|
$
|
219,986
|
|
|
$
|
193,031
|
|
Preferred dividends
|
(18,525
|
)
|
|
(27,340
|
)
|
|
(36,761
|
)
|
|||
Net income available to common stockholders
|
$
|
211,649
|
|
|
$
|
192,646
|
|
|
$
|
156,270
|
|
Net income per share of common stock:
|
|
|
|
|
|
||||||
Basic
|
$
|
1.41
|
|
|
$
|
1.52
|
|
|
$
|
1.54
|
|
Diluted
|
$
|
1.40
|
|
|
$
|
1.48
|
|
|
$
|
1.54
|
|
Basic weighted-average shares of common stock outstanding
|
146,881,231
|
|
|
124,147,073
|
|
|
99,859,153
|
|
|||
Diluted weighted-average shares of common stock outstanding
|
175,794,896
|
|
|
153,821,515
|
|
|
101,232,610
|
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Net income available to common stockholders
|
$
|
211,649
|
|
|
$
|
192,646
|
|
|
$
|
156,270
|
|
Foreign currency translation adjustment
|
—
|
|
|
—
|
|
|
3,811
|
|
|||
Comprehensive income
|
$
|
211,649
|
|
|
$
|
192,646
|
|
|
$
|
160,081
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-In-Capital
|
|
Accumulated
Deficit
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Total
|
||||||||||||||||||
|
Shares
|
|
Par
|
|
Shares
|
|
Par
|
|
|||||||||||||||||||||
Balance at December 31, 2016
|
18,350,000
|
|
|
$
|
184
|
|
|
91,422,676
|
|
|
$
|
914
|
|
|
$
|
1,983,010
|
|
|
$
|
(48,070
|
)
|
|
$
|
(3,811
|
)
|
|
$
|
1,932,227
|
|
Capital increase related to Equity Incentive Plan
|
—
|
|
|
—
|
|
|
200,859
|
|
|
3
|
|
|
10,977
|
|
|
—
|
|
|
—
|
|
|
10,980
|
|
||||||
Issuance of common stock
|
—
|
|
|
—
|
|
|
15,470,000
|
|
|
154
|
|
|
279,673
|
|
|
—
|
|
|
—
|
|
|
279,827
|
|
||||||
Issuance of restricted common stock(1)
|
—
|
|
|
—
|
|
|
27,700
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Redemption of preferred stock
|
(4,679,607
|
)
|
|
(47
|
)
|
|
—
|
|
|
—
|
|
|
(116,955
|
)
|
|
—
|
|
|
—
|
|
|
(117,002
|
)
|
||||||
Preferred stock redemption charge
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,016
|
|
|
—
|
|
|
—
|
|
|
3,016
|
|
||||||
Issuance of Notes
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,002
|
|
|
—
|
|
|
—
|
|
|
11,002
|
|
||||||
Offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(645
|
)
|
|
—
|
|
|
—
|
|
|
(645
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
193,031
|
|
|
—
|
|
|
193,031
|
|
||||||
Change in other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,811
|
|
|
3,811
|
|
||||||
Dividends declared on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(36,761
|
)
|
|
—
|
|
|
(36,761
|
)
|
||||||
Dividends declared on common stock- $1.84 per share
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(191,343
|
)
|
|
—
|
|
|
(191,343
|
)
|
||||||
Balance at December 31, 2017
|
13,670,393
|
|
|
$
|
137
|
|
|
107,121,235
|
|
|
$
|
1,071
|
|
|
$
|
2,170,078
|
|
|
$
|
(83,143
|
)
|
|
$
|
—
|
|
|
$
|
2,088,143
|
|
Capital increase related to Equity Incentive Plan
|
—
|
|
|
—
|
|
|
378,855
|
|
|
5
|
|
|
8,809
|
|
|
—
|
|
|
—
|
|
|
8,814
|
|
||||||
Issuance of common stock
|
—
|
|
|
—
|
|
|
15,525,000
|
|
|
155
|
|
|
275,724
|
|
|
—
|
|
|
—
|
|
|
275,879
|
|
||||||
Issuance of Notes
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,406
|
|
|
—
|
|
|
—
|
|
|
4,406
|
|
||||||
Exchange of Notes for common stock
|
—
|
|
|
—
|
|
|
10,828,475
|
|
|
108
|
|
|
179,908
|
|
|
—
|
|
|
—
|
|
|
180,016
|
|
||||||
Offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(484
|
)
|
|
—
|
|
|
—
|
|
|
(484
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
219,986
|
|
|
—
|
|
|
219,986
|
|
||||||
Dividends declared on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(27,340
|
)
|
|
—
|
|
|
(27,340
|
)
|
||||||
Dividends declared on common stock - $1.84 per share
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(239,673
|
)
|
|
—
|
|
|
(239,673
|
)
|
||||||
Balance at December 31, 2018
|
13,670,393
|
|
|
$
|
137
|
|
|
133,853,565
|
|
|
$
|
1,339
|
|
|
$
|
2,638,441
|
|
|
$
|
(130,170
|
)
|
|
$
|
—
|
|
|
$
|
2,509,747
|
|
Capital increase related to Equity Incentive Plan
|
—
|
|
|
—
|
|
|
466,370
|
|
|
4
|
|
|
10,897
|
|
|
—
|
|
|
—
|
|
|
10,901
|
|
||||||
Conversions of convertible senior notes for common stock
|
—
|
|
|
—
|
|
|
1,967,361
|
|
|
20
|
|
|
33,758
|
|
|
—
|
|
|
—
|
|
|
33,778
|
|
||||||
Issuance of common stock
|
—
|
|
|
—
|
|
|
17,250,000
|
|
|
172
|
|
|
314,985
|
|
|
—
|
|
|
—
|
|
|
315,157
|
|
||||||
Redemption of preferred stock
|
(6,900,000
|
)
|
|
(69
|
)
|
|
—
|
|
|
—
|
|
|
(172,431
|
)
|
|
—
|
|
|
—
|
|
|
(172,500
|
)
|
||||||
Offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(333
|
)
|
|
—
|
|
|
—
|
|
|
(333
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
230,174
|
|
|
—
|
|
|
230,174
|
|
||||||
Dividends declared on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(18,525
|
)
|
|
—
|
|
|
(18,525
|
)
|
||||||
Dividends declared on common stock - $1.84
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(278,424
|
)
|
|
—
|
|
|
(278,424
|
)
|
||||||
Balance at December 31, 2019
|
6,770,393
|
|
|
$
|
68
|
|
|
153,537,296
|
|
|
$
|
1,535
|
|
|
$
|
2,825,317
|
|
|
$
|
(196,945
|
)
|
|
$
|
—
|
|
|
$
|
2,629,975
|
|
|
For the year ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Cash flows (used in) provided by operating activities:
|
|
|
|
|
|
||||||
Net income
|
$
|
230,174
|
|
|
$
|
219,986
|
|
|
$
|
193,031
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
Amortization of discount/premium and PIK
|
(81,611
|
)
|
|
(64,269
|
)
|
|
(48,062
|
)
|
|||
Amortization of deferred financing costs
|
11,969
|
|
|
11,186
|
|
|
6,669
|
|
|||
Equity-based compensation
|
15,897
|
|
|
8,809
|
|
|
10,977
|
|
|||
Unrealized loss on securities
|
—
|
|
|
—
|
|
|
(37,165
|
)
|
|||
Provision for loan losses and impairment, net of reversals
|
20,000
|
|
|
20,000
|
|
|
5,000
|
|
|||
Loss from unconsolidated joint venture
|
—
|
|
|
—
|
|
|
2,259
|
|
|||
Foreign currency (gain) loss
|
3,768
|
|
|
29,617
|
|
|
(18,645
|
)
|
|||
Realized loss on derivative instruments
|
—
|
|
|
—
|
|
|
289
|
|
|||
Unrealized (gain) loss on derivative instruments
|
43,046
|
|
|
(29,345
|
)
|
|
11,523
|
|
|||
Loss on early extinguishment of debt
|
—
|
|
|
2,573
|
|
|
—
|
|
|||
Realized loss on investment
|
12,513
|
|
|
—
|
|
|
42,693
|
|
|||
Changes in operating assets and liabilities:
|
|
|
|
|
|
||||||
Proceeds received from PIK
|
16,469
|
|
|
75,652
|
|
|
—
|
|
|||
Other assets
|
(4,926
|
)
|
|
(10,198
|
)
|
|
(5,192
|
)
|
|||
Loan proceeds held by servicer
|
454
|
|
|
—
|
|
|
(6,306
|
)
|
|||
Accounts payable, accrued expenses and other liabilities
|
5,056
|
|
|
317
|
|
|
(3,351
|
)
|
|||
Payable to related party
|
626
|
|
|
1,636
|
|
|
1,153
|
|
|||
Net cash provided by operating activities
|
273,435
|
|
|
265,964
|
|
|
154,873
|
|
|||
Cash flows used in investing activities:
|
|
|
|
|
|
||||||
New funding of commercial mortgage loans
|
(2,526,384
|
)
|
|
(1,849,100
|
)
|
|
(1,136,252
|
)
|
|||
Add-on funding of commercial mortgage loans
|
(385,508
|
)
|
|
(131,718
|
)
|
|
(82,240
|
)
|
|||
New funding of subordinate loans and other lending assets
|
(493,017
|
)
|
|
(220,809
|
)
|
|
(497,629
|
)
|
|||
Add-on funding of subordinate loans and other lending assets
|
(30,549
|
)
|
|
(149,238
|
)
|
|
(112,637
|
)
|
|||
Proceeds and payments received on commercial mortgage loans
|
1,428,535
|
|
|
675,140
|
|
|
218,002
|
|
|||
Proceeds and payments received on subordinate loans and other lending assets, net
|
560,089
|
|
|
610,051
|
|
|
376,727
|
|
|||
Origination and exit fees received on commercial mortgage and subordinate loans and other lending assets, net
|
45,882
|
|
|
41,822
|
|
|
27,904
|
|
|||
Funding of unconsolidated joint venture
|
—
|
|
|
—
|
|
|
(726
|
)
|
|||
Funding of other assets
|
—
|
|
|
—
|
|
|
(1,379
|
)
|
|||
Payments on settlements of derivative instruments
|
—
|
|
|
—
|
|
|
(201
|
)
|
|||
Increase (decrease) in collateral related to derivative contracts
|
(34,160
|
)
|
|
24,930
|
|
|
(4,952
|
)
|
|||
Payments and proceeds received on securities
|
—
|
|
|
—
|
|
|
468,171
|
|
|||
Proceeds from sale of investments in unconsolidated joint venture
|
—
|
|
|
—
|
|
|
24,498
|
|
|||
Net cash used in investing activities
|
(1,435,112
|
)
|
|
(998,922
|
)
|
|
(720,714
|
)
|
|||
Cash flows from financing activities:
|
|
|
|
|
|
||||||
Proceeds from issuance of common stock
|
315,158
|
|
|
275,879
|
|
|
279,816
|
|
|||
Redemption of preferred stock
|
(172,500
|
)
|
|
—
|
|
|
(116,990
|
)
|
|||
Payment of offering costs
|
(333
|
)
|
|
(484
|
)
|
|
(924
|
)
|
|||
Proceeds from secured debt arrangements
|
3,451,172
|
|
|
2,153,846
|
|
|
1,239,515
|
|
|||
Repayments of secured debt arrangements
|
(2,273,750
|
)
|
|
(1,580,343
|
)
|
|
(1,045,614
|
)
|
|||
Repayments of senior secured term loan principal
|
(2,500
|
)
|
|
—
|
|
|
—
|
|
|||
Proceeds from issuance of senior secured term loan
|
497,500
|
|
|
—
|
|
|
—
|
|
|||
Proceeds from issuance of Notes
|
—
|
|
|
226,550
|
|
|
343,275
|
|
|||
Exchanges and conversions of Notes
|
(704
|
)
|
|
(40,461
|
)
|
|
—
|
|
|||
Repayments of participations sold
|
—
|
|
|
—
|
|
|
(85,081
|
)
|
|||
Payment of deferred financing costs
|
(13,688
|
)
|
|
(15,337
|
)
|
|
(14,254
|
)
|
|||
Other financing activities
|
(4,996
|
)
|
|
—
|
|
|
—
|
|
|||
Dividends on common stock
|
(269,232
|
)
|
|
(227,217
|
)
|
|
(183,877
|
)
|
|||
Dividends on preferred stock
|
(21,974
|
)
|
|
(27,340
|
)
|
|
(35,807
|
)
|
|||
Net cash provided by financing activities
|
1,504,153
|
|
|
765,093
|
|
|
380,059
|
|
|||
Net increase (decrease) in cash and cash equivalents
|
342,476
|
|
|
32,135
|
|
|
(185,782
|
)
|
|||
Cash and cash equivalents, beginning of period
|
109,806
|
|
|
77,671
|
|
|
263,453
|
|
|||
Cash and cash equivalents, end of period
|
$
|
452,282
|
|
|
$
|
109,806
|
|
|
$
|
77,671
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
||||||
Interest paid
|
$
|
133,469
|
|
|
$
|
97,880
|
|
|
$
|
55,835
|
|
Supplemental disclosure of non-cash financing activities:
|
|
|
|
|
|
||||||
Exchange of Notes for common stock
|
$
|
33,778
|
|
|
$
|
180,016
|
|
|
$
|
—
|
|
Dividend declared, not yet paid
|
$
|
74,771
|
|
|
$
|
69,033
|
|
|
$
|
56,576
|
|
Loan proceeds held by servicer
|
$
|
7,775
|
|
|
$
|
1,000
|
|
|
$
|
302,756
|
|
Deferred financing costs, not yet paid
|
$
|
5,193
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Fair Value as of December 31, 2019
|
|
Fair Value as of December 31, 2018
|
||||||||||||||||||||||||||||
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||||||||||
Derivative assets (liabilities), net
|
$
|
—
|
|
|
$
|
(4,876
|
)
|
|
$
|
—
|
|
|
$
|
(4,876
|
)
|
|
$
|
—
|
|
|
$
|
23,700
|
|
|
$
|
—
|
|
|
$
|
23,700
|
|
Interest rate swap liability
|
—
|
|
|
(14,470
|
)
|
|
—
|
|
|
(14,470
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Total
|
$
|
—
|
|
|
$
|
(19,346
|
)
|
|
$
|
—
|
|
|
$
|
(19,346
|
)
|
|
$
|
—
|
|
|
$
|
23,700
|
|
|
$
|
—
|
|
|
$
|
23,700
|
|
Loan Type
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Commercial mortgage loans, net
|
|
$
|
5,326,967
|
|
|
$
|
3,878,981
|
|
Subordinate loans and other lending assets, net
|
|
1,048,126
|
|
|
1,048,612
|
|
||
Total loans, net
|
|
$
|
6,375,093
|
|
|
$
|
4,927,593
|
|
|
|
Principal Balance
|
|
Deferred Fees/Other Items (1)
|
|
Provision for Loan Loss (2)
|
|
Carrying Value
|
||||||||
December 31, 2018
|
|
$
|
4,982,514
|
|
|
$
|
(17,940
|
)
|
|
$
|
(36,981
|
)
|
|
$
|
4,927,593
|
|
New loan fundings
|
|
3,019,401
|
|
|
—
|
|
|
—
|
|
|
3,019,401
|
|
||||
Add-on loan fundings (3)
|
|
416,056
|
|
|
—
|
|
|
—
|
|
|
416,056
|
|
||||
Loan repayments
|
|
(2,037,322
|
)
|
|
—
|
|
|
—
|
|
|
(2,037,322
|
)
|
||||
Gain (loss) on foreign currency translation
|
|
44,338
|
|
|
(689
|
)
|
|
—
|
|
|
43,649
|
|
||||
Realized loss on investment, net of provision for loan loss reversal (2)
|
|
(12,513
|
)
|
|
—
|
|
|
15,000
|
|
|
2,487
|
|
||||
Provision for loan losses
|
|
—
|
|
|
—
|
|
|
(35,000
|
)
|
|
(35,000
|
)
|
||||
Deferred fees
|
|
—
|
|
|
(46,275
|
)
|
|
—
|
|
|
(46,275
|
)
|
||||
PIK interest, amortization of fees and other items
|
|
55,368
|
|
|
29,136
|
|
|
—
|
|
|
84,504
|
|
||||
December 31, 2019
|
|
$
|
6,467,842
|
|
|
$
|
(35,768
|
)
|
|
$
|
(56,981
|
)
|
|
$
|
6,375,093
|
|
(1)
|
Other items primarily consist of purchase discounts or premiums, exit fees and deferred origination expenses, as well as $1.4 million in cost recovery proceeds from a commercial mortgage loan secured by a retail center in Cincinnati, OH.
|
(2)
|
In addition to the $57.0 million provision for loan loss, we recorded an impairment of $3.0 million against an investment previously recorded under other assets on our consolidated balance sheet. During the second quarter of 2019, the underlying collateral on a commercial mortgage loan and a contiguous subordinate loan secured by a multifamily property located in Williston, ND was sold resulting in a realized loss of $12.5 million. Consequently, the previously recorded $15.0 million loan loss provision was reversed.
|
(3)
|
Represents fundings for loans closed prior to 2019.
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Number of loans
|
|
72
|
|
|
69
|
|
||
Principal balance
|
|
$
|
6,467,842
|
|
|
$
|
4,982,514
|
|
Carrying value
|
|
$
|
6,375,093
|
|
|
$
|
4,927,593
|
|
Unfunded loan commitments (1)
|
|
$
|
1,952,887
|
|
|
$
|
1,095,598
|
|
Weighted-average cash coupon (2)
|
|
6.5
|
%
|
|
8.4
|
%
|
||
Weighted-average remaining term (3)
|
|
3.3 years
|
|
|
2.8 years
|
|
||
Weighted-average expected maturity (4)
|
|
1.8 years
|
|
|
1.9 years
|
|
(1)
|
Unfunded loan commitments are primarily funded to finance property improvements or lease-related expenditures by the borrowers. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.
|
(2)
|
For floating rate loans, based on applicable benchmark rates as of the specified dates.
|
(3)
|
Assumes all extension options are exercised.
|
(4)
|
Expected maturity represents our estimated timing of repayments as of December 31, 2019.
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||
Property Type
|
|
Carrying
Value |
|
% of
Portfolio |
|
Carrying
Value |
|
% of
Portfolio |
||||||
Hotel
|
|
$
|
1,660,162
|
|
|
26.0
|
%
|
|
$
|
1,286,590
|
|
|
26.1
|
%
|
Office
|
|
1,401,400
|
|
|
22.0
|
%
|
|
832,620
|
|
|
16.9
|
%
|
||
Residential-for-sale: construction
|
|
692,816
|
|
|
10.9
|
%
|
|
528,510
|
|
|
10.7
|
%
|
||
Residential-for-sale: inventory
|
|
321,673
|
|
|
5.1
|
%
|
|
577,053
|
|
|
11.7
|
%
|
||
Urban Retail
|
|
643,706
|
|
|
10.1
|
%
|
|
—
|
|
|
—
|
%
|
||
Urban Predevelopment
|
|
409,864
|
|
|
6.4
|
%
|
|
683,886
|
|
|
13.9
|
%
|
||
Healthcare
|
|
371,423
|
|
|
5.8
|
%
|
|
156,814
|
|
|
3.2
|
%
|
||
Other
|
|
874,049
|
|
|
13.7
|
%
|
|
862,120
|
|
|
17.5
|
%
|
||
Total
|
|
$
|
6,375,093
|
|
|
100.0
|
%
|
|
$
|
4,927,593
|
|
|
100.0
|
%
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||
Geographic Location
|
|
Carrying
Value |
|
% of
Portfolio |
|
Carrying
Value |
|
% of
Portfolio |
||||||
Manhattan, NY
|
|
$
|
1,793,570
|
|
|
28.1
|
%
|
|
$
|
1,669,145
|
|
|
33.9
|
%
|
Brooklyn, NY
|
|
373,917
|
|
|
5.9
|
%
|
|
346,056
|
|
|
7.0
|
%
|
||
Northeast
|
|
110,771
|
|
|
1.7
|
%
|
|
23,479
|
|
|
0.5
|
%
|
||
West
|
|
728,182
|
|
|
11.4
|
%
|
|
614,160
|
|
|
12.5
|
%
|
||
Midwest
|
|
614,337
|
|
|
9.6
|
%
|
|
631,710
|
|
|
12.8
|
%
|
||
Southeast
|
|
564,166
|
|
|
8.9
|
%
|
|
559,043
|
|
|
11.3
|
%
|
||
United Kingdom
|
|
1,274,390
|
|
|
20.0
|
%
|
|
700,460
|
|
|
14.2
|
%
|
||
Other
|
|
915,760
|
|
|
14.4
|
%
|
|
383,540
|
|
|
7.8
|
%
|
||
Total
|
|
$
|
6,375,093
|
|
|
100.0
|
%
|
|
$
|
4,927,593
|
|
|
100.0
|
%
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||||
Risk Rating
|
|
Number of Loans
|
|
Carrying Value
|
|
% of Loan Portfolio
|
|
Number of Loans
|
|
Carrying Value
|
|
% of Loan Portfolio
|
||||||
1
|
|
—
|
|
$
|
—
|
|
|
—
|
%
|
|
—
|
|
$
|
—
|
|
|
—
|
%
|
2
|
|
8
|
|
348,324
|
|
|
5
|
%
|
|
3
|
|
138,040
|
|
|
3
|
%
|
||
3
|
|
61
|
|
5,707,555
|
|
|
90
|
%
|
|
63
|
|
4,573,930
|
|
|
93
|
%
|
||
4
|
|
1
|
|
182,910
|
|
|
3
|
%
|
|
—
|
|
—
|
|
|
—
|
%
|
||
5
|
|
2
|
|
136,304
|
|
|
2
|
%
|
|
3
|
|
215,623
|
|
|
4
|
%
|
||
|
|
72
|
|
$
|
6,375,093
|
|
|
100
|
%
|
|
69
|
|
$
|
4,927,593
|
|
|
100
|
%
|
Weighted-average risk rating
|
|
|
|
|
|
3.0
|
|
|
|
|
|
|
3.1
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Interest receivable
|
$
|
35,581
|
|
|
$
|
33,399
|
|
Collateral deposited under derivative agreements
|
17,090
|
|
|
—
|
|
||
Other
|
45
|
|
|
321
|
|
||
Total
|
$
|
52,716
|
|
|
$
|
33,720
|
|
|
December 31, 2019 (2)
|
|
December 31, 2018
|
|||||||||||||||||
|
Maximum Amount of Borrowings
|
|
Borrowings Outstanding
|
|
Maturity (1)
|
|
Maximum Amount of Borrowings
|
|
Borrowings Outstanding
|
|
Maturity (1)
|
|||||||||
JPMorgan Facility (USD)
|
$
|
1,154,109
|
|
|
$
|
1,090,160
|
|
|
June 2024
|
|
$
|
1,333,503
|
|
|
$
|
680,141
|
|
|
June 2021
|
|
JPMorgan Facility (GBP)
|
51,702
|
|
|
50,410
|
|
|
June 2024
|
|
48,497
|
|
|
48,497
|
|
|
June 2021
|
|||||
JPMorgan Facility (EUR)
|
94,189
|
|
|
94,189
|
|
|
June 2024
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|||||
DB Repurchase Facility (USD)
|
1,250,000
|
|
|
513,876
|
|
|
March 2021
|
|
904,181
|
|
|
419,823
|
|
|
March 2021
|
|||||
DB Repurchase Facility (GBP)
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
150,819
|
|
|
150,819
|
|
|
March 2021
|
|||||
Goldman Facility (USD)
|
500,000
|
|
|
322,170
|
|
|
November 2021
|
|
300,000
|
|
|
210,072
|
|
|
November 2020
|
|||||
CS Facility - USD
|
226,068
|
|
|
218,644
|
|
|
June 2020
|
|
187,117
|
|
|
187,117
|
|
|
June 2019
|
|||||
CS Facility - GBP
|
93,915
|
|
|
93,915
|
|
|
June 2020
|
|
151,773
|
|
|
151,773
|
|
|
June 2019
|
|||||
HSBC Facility - USD
|
50,625
|
|
|
50,625
|
|
|
October 2020
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|||||
HSBC Facility - GBP
|
34,634
|
|
|
34,634
|
|
|
June 2020
|
|
48,835
|
|
|
48,835
|
|
|
December 2019
|
|||||
HSBC Facility - EUR
|
154,037
|
|
|
154,037
|
|
|
January 2021
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|||||
Barclays Facility (GBP)
|
538,916
|
|
|
290,347
|
|
|
February 2024
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|||||
Barclays Facility (EUR)
|
182,549
|
|
|
182,549
|
|
|
November 2020
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|||||
Sub-total
|
4,330,744
|
|
|
3,095,556
|
|
|
|
|
3,124,725
|
|
|
1,897,077
|
|
|
|
|||||
less: deferred financing costs
|
N/A
|
|
|
(17,190
|
)
|
|
|
|
N/A
|
|
|
(17,555
|
)
|
|
|
|||||
Total / Weighted-Average
|
$
|
4,330,744
|
|
|
$
|
3,078,366
|
|
|
$
|
3,124,725
|
|
|
$
|
1,879,522
|
|
|
||||
(1)
|
Maturity date assumes extensions at our option are exercised.
|
(2)
|
Weighted-average rate as of December 31, 2019 was USD L + 2.07% / GBP L + 1.75% / EUR L + 1.36%.
|
|
Less than
1 year (1) |
|
1 to 3
years (1) |
|
3 to 5
years |
|
More than
5 years |
|
Total
|
||||||||||
JPMorgan Facility
|
$
|
143,841
|
|
|
$
|
251,002
|
|
|
$
|
839,916
|
|
|
$
|
—
|
|
|
$
|
1,234,759
|
|
DB Repurchase Facility
|
32,400
|
|
|
481,476
|
|
|
—
|
|
|
—
|
|
|
513,876
|
|
|||||
Goldman Facility
|
—
|
|
|
322,170
|
|
|
—
|
|
|
—
|
|
|
322,170
|
|
|||||
CS Facility - USD
|
218,644
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
218,644
|
|
|||||
CS Facility - GBP
|
93,915
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
93,915
|
|
|||||
HSBC Facility - USD
|
50,625
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
50,625
|
|
|||||
HSBC Facility - GBP
|
34,634
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
34,634
|
|
|||||
HSBC Facility - EUR
|
—
|
|
|
154,037
|
|
|
—
|
|
|
—
|
|
|
154,037
|
|
|||||
Barclays Facility (GBP)
|
—
|
|
|
—
|
|
|
290,347
|
|
|
—
|
|
|
290,347
|
|
|||||
Barclays Facility (EUR)
|
182,549
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
182,549
|
|
|||||
Total
|
$
|
756,608
|
|
|
$
|
1,208,685
|
|
|
$
|
1,130,263
|
|
|
$
|
—
|
|
|
$
|
3,095,556
|
|
|
|
|
|
|
For the year ended December 31, 2019
|
||||||||||
|
Balance at December 31, 2019
|
|
Amortized Cost of collateral at December 31, 2019
|
|
Maximum Month-End
Balance |
|
Average Month-End
Balance |
||||||||
JPMorgan Facility
|
$
|
1,234,759
|
|
|
$
|
1,845,400
|
|
|
$
|
1,234,759
|
|
|
$
|
947,400
|
|
DB Repurchase Facility
|
513,876
|
|
|
766,676
|
|
|
757,117
|
|
|
604,067
|
|
||||
Goldman Facility
|
322,170
|
|
|
513,559
|
|
|
324,821
|
|
|
246,318
|
|
||||
CS Facility - USD
|
218,644
|
|
|
308,884
|
|
|
218,644
|
|
|
182,646
|
|
||||
CS Facility - GBP
|
93,915
|
|
|
129,723
|
|
|
150,811
|
|
|
134,694
|
|
||||
HSBC Facility - USD
|
50,625
|
|
|
66,960
|
|
|
50,625
|
|
|
50,625
|
|
||||
HSBC Facility - GBP
|
34,634
|
|
|
49,976
|
|
|
50,784
|
|
|
42,296
|
|
||||
HSBC Facility - EUR
|
154,037
|
|
|
190,780
|
|
|
154,037
|
|
|
151,889
|
|
||||
Barclays Facility (GBP)
|
290,347
|
|
|
738,455
|
|
|
290,347
|
|
|
139,004
|
|
||||
Barclays Facility (EUR)
|
182,549
|
|
|
241,674
|
|
|
182,549
|
|
|
181,159
|
|
||||
Total
|
$
|
3,095,556
|
|
|
$
|
4,852,087
|
|
|
|
|
|
|
Principal Amount
|
Coupon Rate
|
Effective Rate (1)
|
Conversion Rate (2)
|
Maturity Date
|
Remaining Period of Amortization
|
|||||
2022 Notes
|
$
|
345,000
|
|
4.75
|
%
|
5.60
|
%
|
50.2260
|
|
8/23/2022
|
2.65 years
|
2023 Notes
|
230,000
|
|
5.38
|
%
|
6.16
|
%
|
48.7187
|
|
10/15/2023
|
3.79 years
|
|
Total
|
$
|
575,000
|
|
|
|
|
|
|
(1)
|
Effective rate includes the effect of the adjustment for the conversion option (See endnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.
|
(2)
|
We have the option to settle any conversions in cash, shares of common stock or a combination thereof. The conversion rate represents the number of shares of common stock issuable per one thousand principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by us to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.
|
Type of Derivative
|
December 31, 2019
|
||||||||
|
Number of Contracts
|
|
Aggregate Notional Amount (in Thousands)
|
|
Notional Currency
|
|
Maturity
|
|
Weighted-Average Years to Maturity
|
Fx Contracts - GBP
|
156
|
|
735,349
|
|
GBP
|
|
January 2020 - December 2024
|
|
1.49
|
Fx Contracts - EUR
|
44
|
|
168,879
|
|
EUR
|
|
February 2020 - August 2024
|
|
3.22
|
Interest Rate Swap
|
1
|
|
500,000
|
|
USD
|
|
May 2026
|
|
6.37
|
Type of Derivative
|
December 31, 2018
|
||||||||
|
Number of Contracts
|
|
Aggregate Notional Amount (in Thousands)
|
|
Notional Currency
|
|
Maturity
|
|
Weighted-Average Years to Maturity
|
Fx Contracts - GBP
|
43
|
|
270,161
|
|
GBP
|
|
January 2019 - November 2020
|
|
0.69
|
|
|
|
Amount of gain (loss)
recognized in income
|
||||||||||
|
Location of Gain (Loss) Recognized in Income
|
|
2019
|
|
2018
|
|
2017
|
||||||
Forward currency contracts
|
Gain (loss) on derivative instruments - unrealized
|
|
$
|
(28,576
|
)
|
|
$
|
29,345
|
|
|
$
|
(11,527
|
)
|
Forward currency contracts
|
Gain (loss) on derivative instruments - realized
|
|
14,151
|
|
|
9,713
|
|
|
(7,657
|
)
|
|||
Interest rate caps (1)
|
Gain on derivative instruments - unrealized
|
|
—
|
|
|
—
|
|
|
4
|
|
|||
Sub-total
|
|
|
$
|
(14,425
|
)
|
|
$
|
39,058
|
|
|
$
|
(19,180
|
)
|
|
|
|
|
|
|
|
|
||||||
Forward currency contracts
|
Loss from unconsolidated joint venture
|
|
—
|
|
|
—
|
|
|
(587
|
)
|
|||
Total
|
|
|
$
|
(14,425
|
)
|
|
$
|
39,058
|
|
|
$
|
(19,767
|
)
|
(1)
|
With a notional amount of $0.0 million, $34.9 million, and $40.2 million at December 31, 2019, 2018, and 2017, respectively.
|
|
|
|
Amount of loss
recognized in income
|
||||||||||
|
Location of Loss Recognized in Income
|
|
2019
|
|
2018
|
|
2017
|
||||||
Interest rate swap (1)
|
Unrealized loss on interest rate swap
|
|
$
|
(14,470
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
(1)
|
With a notional amount of $500.0 million, $0.0 million, and $0.0 million at December 31, 2019, 2018, and 2017, respectively.
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||||||||||
|
Gross Amount of
Recognized Liabilities |
|
Gross Amounts
Offset in the Consolidated Balance Sheet |
|
Net Amounts
of Liabilities Presented in the Consolidated Balance Sheet |
|
Gross
Amount of Recognized Assets |
|
Gross
Amounts Offset in the Consolidated Balance Sheet |
|
Net Amounts
of Assets Presented in the Consolidated Balance Sheet |
||||||||||||
Interest rate swap
|
$
|
(14,470
|
)
|
|
$
|
—
|
|
|
$
|
(14,470
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Forward currency contracts
|
(12,687
|
)
|
|
7,811
|
|
|
(4,876
|
)
|
|
23,753
|
|
|
(53
|
)
|
|
23,700
|
|
||||||
Total derivative instruments
|
$
|
(27,157
|
)
|
|
$
|
7,811
|
|
|
$
|
(19,346
|
)
|
|
$
|
23,753
|
|
|
$
|
(53
|
)
|
|
$
|
23,700
|
|
|
December 31, 2019
|
|
|
December 31, 2018
|
|
||
Accrued dividends payable
|
$
|
74,771
|
|
|
$
|
69,033
|
|
Accrued interest payable
|
16,089
|
|
|
14,208
|
|
||
Accounts payable and other liabilities
|
6,922
|
|
|
1,505
|
|
||
Collateral deposited under derivative agreements
|
2,930
|
|
|
20,000
|
|
||
Total
|
$
|
100,712
|
|
|
$
|
104,746
|
|
|
Type
|
|
Restricted Stock
|
|
RSUs
|
|
Grant Date Fair Value ($ in thousands)
|
|||
Outstanding at December 31, 2016
|
|
150,110
|
|
|
1,703,775
|
|
|
|
||
|
Grant
|
|
27,700
|
|
|
912,916
|
|
|
17,496
|
|
|
Vested
|
|
(72,249
|
)
|
|
(938,541
|
)
|
|
N/A
|
|
|
Forfeiture
|
|
—
|
|
|
(45,404
|
)
|
|
N/A
|
|
Outstanding at December 31, 2017
|
|
105,561
|
|
|
1,632,746
|
|
|
|
||
|
Grant
|
|
28,070
|
|
|
1,006,800
|
|
|
19,148
|
|
|
Vested
|
|
(67,934
|
)
|
|
(739,388
|
)
|
|
N/A
|
|
|
Forfeiture
|
|
—
|
|
|
(47,201
|
)
|
|
N/A
|
|
Outstanding at December 31, 2018
|
|
65,697
|
|
|
1,852,957
|
|
|
|
||
|
Grant
|
|
27,245
|
|
|
1,069,202
|
|
|
20,483
|
|
|
Vested
|
|
(67,586
|
)
|
|
(877,261
|
)
|
|
N/A
|
|
|
Forfeiture
|
|
—
|
|
|
(37,543
|
)
|
|
N/A
|
|
Outstanding at December 31,2019
|
|
25,356
|
|
|
2,007,355
|
|
|
|
Vesting Year
|
Restricted Stock
|
|
RSU
|
|
Total Awards
|
|||
2020
|
25,356
|
|
|
964,829
|
|
|
990,185
|
|
2021
|
—
|
|
|
686,126
|
|
|
686,126
|
|
2022
|
—
|
|
|
356,400
|
|
|
356,400
|
|
Total
|
25,356
|
|
|
2,007,355
|
|
|
2,032,711
|
|
(1)
|
As our aggregate 2019 distributions exceeded our earnings and profits, $0.46 of the January 2020 distribution declared in the fourth quarter of 2019 are payable to common stockholders of record as of December 31, 2019 will be treated as a 2020 distribution for U.S. federal income tax purposes.
|
(2)
|
The Series A Preferred Stock shares were redeemed in full in August 2017.
|
(3)
|
The Series C Preferred Stock shares were redeemed in full in June 2019.
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||
|
Carrying
Value |
|
Estimated
Fair Value |
|
Carrying
Value |
|
Estimated
Fair Value |
||||||||
Cash and cash equivalents
|
$
|
452,282
|
|
|
$
|
452,282
|
|
|
$
|
109,806
|
|
|
$
|
109,806
|
|
Commercial mortgage loans, net
|
5,326,967
|
|
|
5,380,693
|
|
|
3,878,981
|
|
|
3,894,947
|
|
||||
Subordinate loans and other lending assets, net (1)
|
1,048,126
|
|
|
1,050,961
|
|
|
1,048,612
|
|
|
1,047,854
|
|
||||
Secured debt arrangements, net
|
(3,078,366
|
)
|
|
(3,078,366
|
)
|
|
(1,897,077
|
)
|
|
(1,897,077
|
)
|
||||
Senior secured term loan, net
|
(487,961
|
)
|
|
(499,988
|
)
|
|
—
|
|
|
—
|
|
||||
2019 Notes
|
—
|
|
|
—
|
|
|
(34,278
|
)
|
|
(35,276
|
)
|
||||
2022 Notes
|
(337,755
|
)
|
|
(348,060
|
)
|
|
(335,291
|
)
|
|
(326,025
|
)
|
||||
2023 Notes
|
(223,818
|
)
|
|
(234,600
|
)
|
|
(222,431
|
)
|
|
(221,964
|
)
|
(1)
|
As of December 31, 2019 includes subordinate risk retention interests in securitization vehicles with an estimated fair value that approximates their carrying values. We did not hold any such instruments as of December 31, 2018.
|
|
For the year ended
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Basic Earnings
|
|
|
|
|
|
||||||
Net income
|
$
|
230,174
|
|
|
$
|
219,986
|
|
|
$
|
193,031
|
|
Less: Preferred dividends
|
(18,525
|
)
|
|
(27,340
|
)
|
|
(36,761
|
)
|
|||
Net income available to common stockholders
|
$
|
211,649
|
|
|
$
|
192,646
|
|
|
$
|
156,270
|
|
Less: Dividends on participating securities
|
(3,867
|
)
|
|
(3,405
|
)
|
|
(2,913
|
)
|
|||
Basic Earnings
|
$
|
207,782
|
|
|
$
|
189,241
|
|
|
$
|
153,357
|
|
|
|
|
|
|
|
||||||
Diluted Earnings
|
|
|
|
|
|
||||||
Net income
|
$
|
230,174
|
|
|
$
|
219,986
|
|
|
$
|
193,031
|
|
Less: Preferred dividends
|
(18,525
|
)
|
|
(27,340
|
)
|
|
(36,761
|
)
|
|||
Net income available to common stockholders
|
$
|
211,649
|
|
|
$
|
192,646
|
|
|
$
|
156,270
|
|
|
|
|
|
|
|
||||||
Add: Interest expense on Notes
|
35,173
|
|
|
34,779
|
|
|
N/A
|
|
|||
Diluted Earnings
|
$
|
246,822
|
|
|
$
|
227,425
|
|
|
$
|
156,270
|
|
|
|
|
|
|
|
||||||
Number of Shares:
|
|
|
|
|
|
||||||
Basic weighted-average shares of common stock outstanding
|
146,881,231
|
|
|
124,147,073
|
|
|
99,859,153
|
|
|||
Diluted weighted-average shares of common stock outstanding
|
175,794,896
|
|
|
153,821,515
|
|
|
101,232,610
|
|
|||
|
|
|
|
|
|
||||||
Earnings Per Share Attributable to common stockholders
|
|
|
|
|
|
||||||
Basic
|
$
|
1.41
|
|
|
$
|
1.52
|
|
|
$
|
1.54
|
|
Diluted
|
$
|
1.40
|
|
|
$
|
1.48
|
|
|
$
|
1.54
|
|
|
March 31,
|
|
June 30,
|
|
September 30,
|
|
December 31,
|
||||||||||||||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||||||||||
Net interest income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest income from commercial mortgage loans
|
$
|
78,286
|
|
|
$
|
52,114
|
|
|
$
|
77,458
|
|
|
$
|
65,141
|
|
|
$
|
81,136
|
|
|
$
|
71,179
|
|
|
$
|
85,595
|
|
|
$
|
75,275
|
|
Interest income from subordinate loans and other lending assets
|
40,839
|
|
|
33,853
|
|
|
41,043
|
|
|
34,075
|
|
|
43,421
|
|
|
37,308
|
|
|
39,630
|
|
|
34,944
|
|
||||||||
Interest expense
|
(36,295
|
)
|
|
(22,740
|
)
|
|
(33,511
|
)
|
|
(28,437
|
)
|
|
(39,341
|
)
|
|
(31,007
|
)
|
|
(43,779
|
)
|
|
(32,413
|
)
|
||||||||
Net interest income
|
82,830
|
|
|
63,227
|
|
|
84,990
|
|
|
70,779
|
|
|
85,216
|
|
|
77,480
|
|
|
81,446
|
|
|
77,806
|
|
||||||||
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
General and administrative expenses
|
(6,151
|
)
|
|
(4,998
|
)
|
|
(6,574
|
)
|
|
(5,652
|
)
|
|
(5,839
|
)
|
|
(5,843
|
)
|
|
(5,533
|
)
|
|
(3,977
|
)
|
||||||||
Management fees to related party
|
(9,613
|
)
|
|
(8,092
|
)
|
|
(10,259
|
)
|
|
(9,013
|
)
|
|
(10,434
|
)
|
|
(9,515
|
)
|
|
(10,428
|
)
|
|
(9,804
|
)
|
||||||||
Total operating expenses
|
(15,764
|
)
|
|
(13,090
|
)
|
|
(16,833
|
)
|
|
(14,665
|
)
|
|
(16,273
|
)
|
|
(15,358
|
)
|
|
(15,961
|
)
|
|
(13,781
|
)
|
||||||||
Other income
|
518
|
|
|
203
|
|
|
484
|
|
|
343
|
|
|
429
|
|
|
427
|
|
|
682
|
|
|
465
|
|
||||||||
Reversal of (provision for) loan losses and impairments
|
—
|
|
|
—
|
|
|
15,000
|
|
|
(5,000
|
)
|
|
(35,000
|
)
|
|
—
|
|
|
—
|
|
|
(15,000
|
)
|
||||||||
Realized loss on investments
|
—
|
|
|
—
|
|
|
(12,513
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Foreign currency gain (loss)
|
6,894
|
|
|
10,125
|
|
|
(7,777
|
)
|
|
(29,649
|
)
|
|
(19,129
|
)
|
|
(4,050
|
)
|
|
39,830
|
|
|
(6,761
|
)
|
||||||||
Loss on early extinguishment of debt
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,573
|
)
|
|
—
|
|
|
—
|
|
||||||||
Gain (loss) on foreign currency forwards
|
(6,720
|
)
|
|
(11,032
|
)
|
|
11,186
|
|
|
33,538
|
|
|
24,153
|
|
|
6,291
|
|
|
(43,044
|
)
|
|
10,261
|
|
||||||||
Gain (loss) on interest rate swap
|
—
|
|
|
—
|
|
|
(13,113
|
)
|
|
—
|
|
|
(10,307
|
)
|
|
—
|
|
|
8,950
|
|
|
—
|
|
||||||||
Net income
|
$
|
67,758
|
|
|
$
|
49,433
|
|
|
$
|
61,424
|
|
|
$
|
55,346
|
|
|
$
|
29,089
|
|
|
$
|
62,217
|
|
|
$
|
71,903
|
|
|
$
|
52,990
|
|
Preferred dividends
|
(6,835
|
)
|
|
(6,835
|
)
|
|
(4,919
|
)
|
|
(6,834
|
)
|
|
(3,385
|
)
|
|
(6,836
|
)
|
|
(3,386
|
)
|
|
(6,835
|
)
|
||||||||
Net income available to common stockholders
|
$
|
60,923
|
|
|
$
|
42,598
|
|
|
$
|
56,505
|
|
|
$
|
48,512
|
|
|
$
|
25,704
|
|
|
$
|
55,381
|
|
|
$
|
68,517
|
|
|
$
|
46,155
|
|
Net income per share of common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Basic
|
$0.45
|
|
$0.38
|
|
$0.38
|
|
$0.39
|
|
$0.16
|
|
$0.42
|
|
$0.44
|
|
$0.34
|
||||||||||||||||
Diluted
|
$0.43
|
|
$0.38
|
|
$0.37
|
|
$0.39
|
|
$0.16
|
|
$0.40
|
|
$0.42
|
|
$0.34
|
||||||||||||||||
Basic weighted-average shares of common stock outstanding
|
134,607,107
|
|
110,211,853
|
|
145,567,963
|
|
123,019,993
|
|
153,531,678
|
|
129,188,343
|
|
153,537,074
|
|
133,852,915
|
||||||||||||||||
Diluted weighted-average shares of common stock outstanding
|
164,683,086
|
|
111,871,429
|
|
174,101,234
|
|
124,629,317
|
|
153,531,678
|
|
153,918,435
|
|
182,070,345
|
|
163,900,633
|
||||||||||||||||
Dividend declared per share of common stock
|
$0.46
|
|
$0.46
|
|
$0.46
|
|
$0.46
|
|
$0.46
|
|
$0.46
|
|
$0.46
|
|
$0.46
|
(1)
|
Assumes applicable benchmark rate as of December 31, 2019 for all floating rate loans
|
(2)
|
Assumes all extension options are exercised.
|
(3)
|
Subject to prior liens of approximately $4.3 billion.
|
(4)
|
The aggregate cost for U.S. federal income tax purposes is $6.4 billion.
|
|
|
|
|
Year Ended
|
|
Year Ended
|
||||
Reconciliation of Carrying Amount of Loans
|
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Balance at beginning of year
|
|
$
|
4,927,593
|
|
|
$
|
3,679,758
|
|
||
Loan fundings (1)
|
|
3,435,457
|
|
|
2,350,865
|
|
||||
Loan repayments (2)
|
|
(2,037,322
|
)
|
|
(1,066,843
|
)
|
||||
Gain (loss) on foreign currency translation
|
|
43,649
|
|
|
(51,013
|
)
|
||||
Realized loss on investment, net of provision for loan loss reversal (3)
|
|
2,487
|
|
|
—
|
|
||||
Provision for loan losses (4)
|
|
(35,000
|
)
|
|
(20,000
|
)
|
||||
Deferred Fees
|
|
(46,275
|
)
|
|
(34,066
|
)
|
||||
PIK interest, amortization of fees and other items (5)
|
|
84,504
|
|
|
68,892
|
|
||||
Balance at the close of year
|
|
$
|
6,375,093
|
|
|
$
|
4,927,593
|
|
(1)
|
During the year ended December 31, 2018, $34.6 million was purchased from a fund managed by an affiliate of the Manager.
|
(2)
|
During the year ended December 31, 2019, we sold $152.6 million in mezzanine loans secured by an urban retail property to two funds managed by an affiliate of the Manager.
|
(3)
|
During the second quarter of 2019, the underlying collateral on a commercial mortgage loan and a contiguous subordinate loan secured by a multifamily property located in Williston, ND was sold resulting in a realized loss of $12.5 million. Consequently, the previously recorded $15.0 million loan loss provision was reversed.
|
(4)
|
During the year ended December 31, 2019, we recorded $35.0 million for provision for loan losses and impairments, comprised of a (i) $32.0 million loan loss provision recorded against a commercial mortgage loan secured by a retail center located in Cincinnati, OH, and (ii) $3.0 million loan loss provision recorded against a commercial mortgage loan secured by a fully-built, for-sale residential condominium units located in Bethesda, MD. During the year ended December 31, 2018, we recorded $20.0 million for provision for loan losses and impairments, comprised of a (i) $15.0 million and (ii) $5.0 million loan loss provision against the same loans as in 2019, respectively.
|
(5)
|
Other items primarily consist of purchase discounts or premiums, exit fees and deferred origination expenses, as well as $1.4 million in cost recovery proceeds from a commercial mortgage loan secured by a retail center in Cincinnati, OH.
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
|
Item 9A.
|
Controls and Procedures.
|
•
|
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
|
•
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and our expenditures are being made only in accordance with authorizations of our management and directors; and
|
•
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
|
Item 9B.
|
Other Information.
|
Item 10.
|
Directors, Executive Officers and Corporate Governance.
|
Item 11.
|
Executive Compensation.
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence.
|
Item 14.
|
Principal Accountant Fees and Services.
|
Item 15.
|
Exhibits, Financial Statement Schedules.
|
3.1
|
|
|
|
|
|
3.2
|
|
|
|
|
|
3.3
|
|
|
|
|
|
4.1
|
|
|
|
|
|
4.2
|
|
|
|
|
|
4.3
|
|
|
|
|
|
4.4
|
|
|
|
|
|
4.5
|
|
|
|
|
|
4.6*
|
|
|
|
|
|
10.1
|
|
|
|
|
|
10.2
|
|
|
|
|
|
10.3
|
|
|
|
|
|
10.4
|
|
|
|
|
|
10.5
|
|
|
|
|
|
10.6
|
|
|
|
|
|
10.7
|
|
|
|
|
|
10.8
|
|
|
|
|
|
10.9
|
|
|
|
|
|
10.10
|
|
|
|
|
|
10.11
|
|
|
|
|
|
10.12
|
|
|
|
|
|
21.1*
|
|
|
|
|
|
23.1*
|
|
|
|
|
|
31.1*
|
|
|
|
|
|
31.2*
|
|
|
|
|
|
32.1*
|
|
|
|
|
|
101.INS*
|
|
Inline XBRL Instance Document
|
|
|
|
101.SCH*
|
|
Inline XBRL Taxonomy Extension Schema
|
|
|
|
101.CAL*
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
101.DEF*
|
|
Inline XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
101.LAB*
|
|
Inline XBRL Taxonomy Extension Label Linkbase
|
|
|
|
101.PRE*
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase
|
|
|
|
104*
|
|
Cover Page Interactive Data File (embedded with the Inline XBRL document)
|
*
|
Filed herewith.
|
Item 16.
|
Form 10-K Summary.
|
|
Apollo Commercial Real Estate Finance, Inc.
|
||
|
|
|
|
February 13, 2020
|
By:
|
|
/s/ Stuart A. Rothstein
|
|
|
|
Stuart A. Rothstein
|
|
|
|
President and Chief Executive Officer
|
February 13, 2020
|
By:
|
|
/s/ Stuart A. Rothstein
|
|
|
|
Stuart A. Rothstein
President, Chief Executive Officer and Director
(Principal Executive Officer)
|
|
|
|
|
February 13, 2020
|
By:
|
|
/s/ Jai Agarwal
|
|
|
|
Jai Agarwal
Chief Financial Officer, Treasurer, Secretary
(Principal Financial Officer and Principal Accounting Officer)
|
|
|
|
|
February 13, 2020
|
By:
|
|
/s/ Mark C. Biderman
|
|
|
|
Mark C. Biderman
Director
|
|
|
|
|
February 13, 2020
|
By:
|
|
/s/ Robert A. Kasdin
|
|
|
|
Robert A. Kasdin
Director
|
|
|
|
|
February 13, 2020
|
By:
|
|
/s/ Cindy Z. Michel
|
|
|
|
Cindy Z. Michel
Director
|
|
|
|
|
February 13, 2020
|
By:
|
|
/s/ Eric L. Press
|
|
|
|
Eric L. Press
Director
|
|
|
|
|
February 13, 2020
|
By:
|
|
/s/ Scott S. Prince
|
|
|
|
Scott S. Prince
Director
|
|
|
|
|
February 13, 2020
|
By:
|
|
/s/ Michael E. Salvati
|
|
|
|
Michael E. Salvati
Director
|
|
|
|
|
(i)
|
the acquisition by any person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange Act, of beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions of shares of our stock entitling that person to exercise more than 50% of the total voting power of all shares of our stock entitled to vote generally in elections of directors (except that such person will be deemed to have beneficial ownership of all securities that such person has the right to acquire, whether such right is currently exercisable or is exercisable only upon the occurrence of a subsequent condition); and
|
(ii)
|
following the closing of any transaction referred to in clause (i) above, neither we nor the acquiring or surviving
|
•
|
any person from beneficially or constructively owning, applying certain attribution rules of the Internal Revenue Code, shares of our stock that would result in our being “closely held” under Section 856(h) of the Internal Revenue Code (without regard to whether the ownership interest is held during the last half of a taxable year) or otherwise cause us to fail to qualify as a REIT; and
|
•
|
any person from transferring shares of our stock if such transfer would result in shares of our stock being beneficially owned by fewer than 100 persons (determined without reference to any rules of attribution).
|
•
|
to rescind as void any vote cast by a prohibited owner prior to our discovery that the shares have been transferred to the trust; and
|
•
|
to recast the vote in accordance with the desires of the trustee acting for the benefit of the beneficiary of the trust.
|
1.
|
Registration Statement No. 333-221483 on Form S-3 pertaining to Apollo Commercial Real Estate Finance Inc.’s Direct Stock Purchase and Dividend Reinvestment Plan
|
2.
|
Registration Statement No. 333-224695 on Form S-3 pertaining to the offering from time to time of Common Stock, Preferred Stock, Depositary Shares, Debt Securities, Warrants and Rights
|
3.
|
Registration Statement No. 333-234545 on Form S-3 pertaining to the offering and resale from time to time of 10,493,529 shares of Common Stock and 6,770,393 shares of 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock.
|
4.
|
Registration Statement No. 333-177556 on Form S-3 pertaining to the offering and resale from time to time of 3,495,000 shares of Common Stock
|
5.
|
Registration Statement No. 333-232660 on Form S-8 pertaining to the Amended and Restated Apollo Commercial Real Estate Finance, Inc. 2019 Equity Incentive Plan
|
1.
|
I have reviewed this annual report on Form 10-K of Apollo Commercial Real Estate Finance, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 13, 2020
|
By:
|
|
/s/ Stuart A. Rothstein
|
|
Name:
|
|
Stuart A. Rothstein
|
|
Title:
|
|
President and Chief Executive Officer
|
1.
|
I have reviewed this annual report on Form 10-K of Apollo Commercial Real Estate Finance, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: February 13, 2020
|
By:
|
|
/s/ Jai Agarwal
|
|
Name:
|
|
Jai Agarwal
|
|
Title:
|
|
Chief Financial Officer, Treasurer and Secretary
|
Date: February 13, 2020
|
By:
|
|
/s/ Stuart A. Rothstein
|
|
Name:
|
|
Stuart A. Rothstein
|
|
Title:
|
|
President and Chief Executive Officer
|
Date: February 13, 2020
|
By:
|
|
/s/ Jai Agarwal
|
|
Name:
|
|
Jai Agarwal
|
|
Title:
|
|
Chief Financial Officer, Treasurer and Secretary
|